214 related articles for article (PubMed ID: 24338272)
1. Long-lasting complete response of metastatic melanoma to ipilimumab with analysis of the resident immune cells.
Tsaknakis B; Schaefer IM; Schwörer H; Sahlmann CO; Thoms KM; Blaschke M; Ramadori G; Cameron S
Med Oncol; 2014 Jan; 31(1):813. PubMed ID: 24338272
[TBL] [Abstract][Full Text] [Related]
2. Ipilimumab-dependent cell-mediated cytotoxicity of regulatory T cells ex vivo by nonclassical monocytes in melanoma patients.
Romano E; Kusio-Kobialka M; Foukas PG; Baumgaertner P; Meyer C; Ballabeni P; Michielin O; Weide B; Romero P; Speiser DE
Proc Natl Acad Sci U S A; 2015 May; 112(19):6140-5. PubMed ID: 25918390
[TBL] [Abstract][Full Text] [Related]
3. Lentigo maligna: review of salient characteristics and management.
Kallini JR; Jain SK; Khachemoune A
Am J Clin Dermatol; 2013 Dec; 14(6):473-80. PubMed ID: 24019181
[TBL] [Abstract][Full Text] [Related]
4. Lentigo maligna: diagnosis and treatment.
Bosbous MW; Dzwierzynski WW; Neuburg M
Clin Plast Surg; 2010 Jan; 37(1):35-46. PubMed ID: 19914456
[TBL] [Abstract][Full Text] [Related]
5. Use of reflectance confocal microscopy to monitor response of lentigo maligna to nonsurgical treatment.
Nadiminti H; Scope A; Marghoob AA; Busam K; Nehal KS
Dermatol Surg; 2010 Feb; 36(2):177-84. PubMed ID: 20039914
[No Abstract] [Full Text] [Related]
6. Immunocryosurgery as monotherapy for lentigo maligna or combined with surgical excision for lentigo maligna melanoma.
Matas-Nadal C; Sòria X; García-de-la-Fuente MR; Huerva V; Ortega E; Vilardell F; Gatius S; Casanova JM; Martí RM
J Dermatol; 2018 May; 45(5):564-570. PubMed ID: 29430695
[TBL] [Abstract][Full Text] [Related]
7. [Dubreuilh melanoma(lentigo maligna melanoma)].
Ollivaud L; Basset-Seguin N; Archimbaud A
Ann Dermatol Venereol; 2001 Feb; 128(2):172-6. PubMed ID: 11275603
[No Abstract] [Full Text] [Related]
8. Tumor infiltrating lymphocytes in lymph node metastases of stage III melanoma correspond to response and survival in nine patients treated with ipilimumab at the time of stage IV disease.
Diem S; Hasan Ali O; Ackermann CJ; Bomze D; Koelzer VH; Jochum W; Speiser DE; Mertz KD; Flatz L
Cancer Immunol Immunother; 2018 Jan; 67(1):39-45. PubMed ID: 28894934
[TBL] [Abstract][Full Text] [Related]
9. Treatments and associated outcomes of acral lentiginous melanoma: A review.
Lobl MB; Santos C; Clarey D; Higgins S; Silva-Lopez E; Sutton A; Wysong A
J Am Acad Dermatol; 2020 Jul; 83(1):230-234. PubMed ID: 31738961
[No Abstract] [Full Text] [Related]
10. Widespread biphasic amyloidosis related to ipilimumab treatment for metastatic melanoma.
Velasco-Tamariz V; Burillo-Martínez S; Prieto-Barrios M; Calleja-Algarra A; Rodríguez-Peralto JL; Ortiz-Romero PL
Int J Dermatol; 2017 Sep; 56(9):e189-e191. PubMed ID: 28500627
[No Abstract] [Full Text] [Related]
11. Lentigo maligna and malignant melanoma in situ, lentigo maligna type.
Flotte TJ; Mihm MC
Hum Pathol; 1999 May; 30(5):533-6. PubMed ID: 10333223
[TBL] [Abstract][Full Text] [Related]
12. Lentigo maligna.
Samaniego E; Redondo P
Actas Dermosifiliogr; 2013 Nov; 104(9):757-75. PubMed ID: 22857817
[TBL] [Abstract][Full Text] [Related]
13. CTLA-4 blockade increases antigen-specific CD8(+) T cells in prevaccinated patients with melanoma: three cases.
Yuan J; Ginsberg B; Page D; Li Y; Rasalan T; Gallardo HF; Xu Y; Adams S; Bhardwaj N; Busam K; Old LJ; Allison JP; Jungbluth A; Wolchok JD
Cancer Immunol Immunother; 2011 Aug; 60(8):1137-46. PubMed ID: 21465316
[TBL] [Abstract][Full Text] [Related]
14. The Abscopal Effect in the Era of Checkpoint Inhibitors.
Kodet O; Němejcova K; Strnadová K; Havlínová A; Dundr P; Krajsová I; Štork J; Smetana K; Lacina L
Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281259
[TBL] [Abstract][Full Text] [Related]
15. Ipilimumab induces simultaneous regression of melanocytic naevi and melanoma metastases.
Libon F; Arrese JE; Rorive A; Nikkels AF
Clin Exp Dermatol; 2013 Apr; 38(3):276-9. PubMed ID: 23020081
[TBL] [Abstract][Full Text] [Related]
16. [Lentigo maligna: a special melanoma].
Le Gal FA; Toutous-Trellu L; Kaya G; Salomon D
Rev Med Suisse; 2011 Apr; 7(289):765-6, 768-71. PubMed ID: 21568099
[TBL] [Abstract][Full Text] [Related]
17. Treatment options in melanoma in situ: topical and radiation therapy, excision and Mohs surgery.
Erickson C; Miller SJ
Int J Dermatol; 2010 May; 49(5):482-91. PubMed ID: 20534080
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of immune response in resectable colorectal liver metastases treated by surgery alone or surgery with perioperative FOLFOX in the randomised EORTC study 40983.
Tanis E; Julié C; Emile JF; Mauer M; Nordlinger B; Aust D; Roth A; Lutz MP; Gruenberger T; Wrba F; Sorbye H; Bechstein W; Schlag P; Fisseler A; Ruers T
Eur J Cancer; 2015 Nov; 51(17):2708-17. PubMed ID: 26342674
[TBL] [Abstract][Full Text] [Related]
19. Evidence-Based Clinical Practice Guidelines for the Management of Patients with Lentigo Maligna.
Robinson M; Primiero C; Guitera P; Hong A; Scolyer RA; Stretch JR; Strutton G; Thompson JF; Soyer HP
Dermatology; 2020; 236(2):111-116. PubMed ID: 31639788
[TBL] [Abstract][Full Text] [Related]
20. Ipilimumab: a novel immunostimulatory monoclonal antibody for the treatment of cancer.
Graziani G; Tentori L; Navarra P
Pharmacol Res; 2012 Jan; 65(1):9-22. PubMed ID: 21930211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
